Schonfeld Strategic Advisors LLC Mereo Biopharma Group PLC Transaction History

Schonfeld Strategic Advisors LLC

$15 Billion
Q1 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 1,591,056 shares of MREO stock, worth $3.68 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,591,056

Previous 493,900 222.14%

Holding current value

$3.68 Million

Previous $1.73 Million 107.12%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$2.25 - $3.76 $2.47 Million - $4.13 Million	1,097,156 Added 222.14%	1,591,056 $3.58 Million
Q4 2024 Feb 14, 2025	BUY	$3.29 - $4.62 $1.62 Million - $2.28 Million	493,900 New	493,900 $1.73 Million
Q4 2023 Feb 14, 2024	SELL	$1.19 - $2.42 $95,795 - $194,810	-80,500 Reduced 61.64%	50,100 $115,000
Q3 2023 Nov 14, 2023	BUY	$1.15 - $1.67 $114 - $167	100 Added 0.08%	130,600 $168,000
Q2 2023 Aug 14, 2023	SELL	$0.79 - $1.43 $23,779 - $43,043	-30,100 Reduced 18.74%	130,500 $172,000
Q1 2023 May 15, 2023	BUY	$0.71 - $1.22 $3,266 - $5,612	4,600 Added 2.95%	160,600 $114,000
Q4 2022 Feb 14, 2023	BUY	$0.5 - $1.01 $2,300 - $4,646	4,600 Added 3.04%	156,000 $117,000
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.73 $462,722 - $976,232	-564,296 Reduced 78.85%	151,400 $130,000
Q2 2022 Aug 15, 2022	SELL	$0.33 - $1.69 $53,930 - $276,191	-163,427 Reduced 18.59%	715,696 $802,000
Q1 2022 May 16, 2022	BUY	$1.04 - $1.7 $164,663 - $269,161	158,330 Added 21.97%	879,123 $984,000
Q4 2021 Feb 14, 2022	SELL	$1.51 - $2.59 $151,000 - $259,000	-100,000 Reduced 12.18%	720,793 $1.15 Million
Q3 2021 Nov 16, 2021	SELL	$2.2 - $3.17 $1.11 Million - $1.6 Million	-504,260 Reduced 38.06%	820,793 $1.99 Million
Q2 2021 Aug 16, 2021	BUY	$2.94 - $4.08 $152,880 - $212,160	52,000 Added 4.08%	1,325,053 $4.2 Million
Q1 2021 May 17, 2021	BUY	$2.6 - $4.43 $299,137 - $509,684	115,053 Added 9.94%	1,273,053 $4.29 Million
Q4 2020 Feb 16, 2021	BUY	$1.95 - $3.6 $1.59 Million - $2.93 Million	814,805 Added 237.42%	1,158,000 $4.15 Million
Q3 2020 Nov 16, 2020	BUY	$2.55 - $3.29 $875,147 - $1.13 Million	343,195 New	343,195 $1,000

Others Institutions Holding MREO

# of Institutions

100

Shares Held

112M

Call Options Held

Put Options Held

668K

View Full List

About Mereo Biopharma Group plc

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $289M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

More about MREO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Mereo Biopharma Group PLC Transaction History